Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (7888)	6/11/1999 7:02:00 AM
From: fossilg	Read Replies (1) \| Respond to of 9523

wow what a wind-bag,is the split on or off?????????

To: Mike McFarland who wrote (7888)	6/11/1999 1:42:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 9523

No comment on the error in my first sentence? Of course PFE has lost a number equal to 50% of it's current market capitilization, silly me-- folks make that error all the time. The loss was of course about a third--and a gain of 50% is now required from these levels to regain it's lofty price. There is an article at iionline today about the valuation of Pfizer...here is the url: iionline.com I guess some bulls like it at $100... The R&D budget is simply amazing, and that is not a point lost on me as I muck down in third tier. However, I will continue to slog around in things which trade closer to book value, surely these little biotechnology companies have to be a great target for pharma in these hard times for biotech financing. And while you hate to see all that paper money deflate in the stock, pharma is still fabulously rich.